EUVIMEDEUVIMED entdecken
Open Access

CDK4 Mediates Cisplatin Resistance in Renal Cell Carcinoma (RCC) Cells by Regulating the ASH1L-CTR1 Axis

Wenjian Zeng, Xianglong Li, Hao Cai, Qingyu Zhou, Shuangshuang Sun, Pingping Li, Sunlong Li, Zhi Chen

Oncology Research · 2026 · 34 (6) · 1-10

DOI: 10.32604/or.2026.073934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Wenjian Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Cisplatin, Cyclin-Dependent Kinase 4, Carcinoma, Renal Cell, Drug Resistance, Neoplasm. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinCyclin-Dependent Kinase 4Carcinoma, Renal CellDrug Resistance, NeoplasmKidney NeoplasmsHistone-Lysine N-MethyltransferaseDNA-Binding ProteinsCation Transport ProteinsTranscription FactorsHumansAnimalsMiceCell Line, TumorGene Expression Regulation, NeoplasticCopper Transporter 1MaleXenograft Model Antitumor AssaysAntineoplastic AgentsFemaleCell ProliferationPrognosisMice, Nude

Stichwörter der Autor:innen

ASH1-Like Histone Lysine Methyltransferase (ASH1L)Renal cell carcinomacisplatin resistancecopper transporter 1 (CTR1)cyclin-dependent kinase 4 (CDK4)molecular mechanism

Substanzen

CisplatinCyclin-Dependent Kinase 4CDK4 protein, humanHistone-Lysine N-MethyltransferaseCopper Transporter 1SLC31A1 protein, humanDNA-Binding ProteinsCation Transport ProteinsAntineoplastic AgentsTranscription Factors

Autor:innen und Institutionen

  • Department of Oncology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Chemotherapy, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Zitieren

APA

Zeng, W., Li, X., Cai, H., Zhou, Q., Sun, S., Li, P., Li, S., & Chen, Z. (2026). CDK4 Mediates Cisplatin Resistance in Renal Cell Carcinoma (RCC) Cells by Regulating the ASH1L-CTR1 Axis. Oncology Research, 34(6), 1-10. https://doi.org/10.32604/or.2026.073934

Vancouver

Zeng W, Li X, Cai H, Zhou Q, Sun S, Li P, et al. CDK4 Mediates Cisplatin Resistance in Renal Cell Carcinoma (RCC) Cells by Regulating the ASH1L-CTR1 Axis. Oncology Research. 2026;34(6):1-10. doi:10.32604/or.2026.073934

BibTeX
@article{Zeng2026,
  author = {Zeng, Wenjian and Li, Xianglong and Cai, Hao and Zhou, Qingyu and Sun, Shuangshuang and Li, Pingping and Li, Sunlong and Chen, Zhi},
  title = {CDK4 Mediates Cisplatin Resistance in Renal Cell Carcinoma (RCC) Cells by Regulating the ASH1L-CTR1 Axis},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {6},
  pages = {1--10},
  doi = {10.32604/or.2026.073934}
}
Kostenlos starten →